<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neurosurgery Blog &#187; Surgical technique</title>
	<atom:link href="http://www.neurosurgery-blog.com/archives/category/surgical-technique/feed" rel="self" type="application/rss+xml" />
	<link>http://www.neurosurgery-blog.com</link>
	<description>Daily bibliographic and video review of the Neurosurgery Department. La Fe University Hospital. Valencia, Spain</description>
	<lastBuildDate>Thu, 09 Feb 2012 23:00:45 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Comparative Evaluation of Percutaneous Retrogasserian Glycerol Rhizolysis and Radiofrequency Thermocoagulation Techniques in the Management of Trigeminal Neuralgia</title>
		<link>http://www.neurosurgery-blog.com/archives/3788</link>
		<comments>http://www.neurosurgery-blog.com/archives/3788#comments</comments>
		<pubDate>Mon, 06 Feb 2012 23:00:19 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Anhydrous glycerol]]></category>
		<category><![CDATA[Radiofrequency thermocoagulation]]></category>
		<category><![CDATA[Trigeminal neuralgia]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3788</guid>
		<description><![CDATA[Neurosurgery 70:407–413, 2012 DOI: 10.1227/NEU.0b013e318233a85f
Among the percutaneous procedures for the treatment of trigeminal neuralgia, percutaneous anhydrous glycerol rhizolysis (PRGR) and radiofrequency (RF) ablation of trigeminal neuralgia have stood the test of time.
OBJECTIVE: A prospective study was conducted to compare PRGR and RF ablation techniques in patients with trigeminal neuralgia in terms of (1) efficacy of [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/Trigeminal-neuralgia.jpg"><img class="alignleft size-thumbnail wp-image-3792" title="Trigeminal neuralgia" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/Trigeminal-neuralgia-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 70:407–413, 2012 DOI: 10.1227/NEU.0b013e318233a85f</strong></p>
<p style="text-align: justify;">Among the percutaneous procedures for the treatment of trigeminal neuralgia, percutaneous anhydrous glycerol rhizolysis (PRGR) and radiofrequency (RF) ablation of trigeminal neuralgia have stood the test of time.</p>
<p style="text-align: justify;">OBJECTIVE: A prospective study was conducted to compare PRGR and RF ablation techniques in patients with trigeminal neuralgia in terms of (1) efficacy of pain relief, (2) duration of pain relief and (3) side effects.</p>
<p style="text-align: justify;">METHODS: All patients presenting to our pain clinic for the first time for the treatment of trigeminal neuralgia were enrolled to receive either PRGR or RF ablation; the treatment was chosen by the patient. Demographic data, magnetic resonance imaging scan, relevant medical disease, amount of anhydrous glycerol, lesion temperature, and total duration of RF were noted. The presence or absence of cerebrospinal fluid egress, immediate pain relief, duration of pain-free period, need for repeat injection or additional peripheral nerve block, and recurrence of pain were also noted. The degree of pain relief was recorded every 3 months. Any complications during the procedure and side effects were also recorded.</p>
<p style="text-align: justify;">RESULTS: Seventy-nine patients underwent either PRGR (n = 40) or RF thermocoagulation (n = 39). A total of 23 patients (58.9%) in the PRGR group and 33 patients (84.6%) in the RF group experienced excellent pain relief. The mean duration of excellent pain relief in the PRGR and RF groups was comparable. By the end of the study period, 39.1% patients in the PRGR group and 51.5% patients in the RF group experienced recurrence of pain.</p>
<p style="text-align: justify;">CONCLUSION: Both PRGR and RF techniques can achieve acceptable pain relief with minimal side effects.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3788/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Accuracy of Diffusion Tensor Magnetic Resonance Imaging-Based Tractography for Surgery of Gliomas Near the Pyramidal Tract</title>
		<link>http://www.neurosurgery-blog.com/archives/3776</link>
		<comments>http://www.neurosurgery-blog.com/archives/3776#comments</comments>
		<pubDate>Thu, 02 Feb 2012 23:00:26 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Neuronavigation]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[diffusion tensor imaging]]></category>
		<category><![CDATA[Glioma]]></category>
		<category><![CDATA[magnetic resonance imaging]]></category>
		<category><![CDATA[Pyramidal tract]]></category>
		<category><![CDATA[tractography]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3776</guid>
		<description><![CDATA[Neurosurgery 70:283–294, 2012 DOI: 10.1227/NEU.0b013e31823020e6
Diffusion tensor (DT) imaging-based fiber tracking is a noninvasive magnetic resonance technique that can delineate the course of white matter fibers.
OBJECTIVE: To evaluate the accuracy and usefulness of this DT imaging-based fiber tracking for surgery in patients with gliomas near the pyramidal tract (PT).
METHODS: Subjects comprised 32 patients with gliomas near [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/Accuracy_of_Diffusion_Tensor_Magnetic_Resonance.jpg"><img class="alignleft size-thumbnail wp-image-3778" title="Accuracy_of_Diffusion_Tensor_Magnetic_Resonance" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/Accuracy_of_Diffusion_Tensor_Magnetic_Resonance-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 70:283–294, 2012 DOI: 10.1227/NEU.0b013e31823020e6</strong></p>
<p style="text-align: justify;">Diffusion tensor (DT) imaging-based fiber tracking is a noninvasive magnetic resonance technique that can delineate the course of white matter fibers.</p>
<p style="text-align: justify;">OBJECTIVE: To evaluate the accuracy and usefulness of this DT imaging-based fiber tracking for surgery in patients with gliomas near the pyramidal tract (PT).</p>
<p style="text-align: justify;">METHODS: Subjects comprised 32 patients with gliomas near the PT. DT imagingbased fiber tracks of the PT were generated before and within 3 days after surgery in all patients. A tractography-integrated navigation system was used during the operation. Cortical and subcortical motor-evoked potentials (MEPs) were also monitored during resection to maximize the preservation of motor function. The threshold intensity for subcortical MEPs was examined by searching the stimulus points and changing the stimulus intensity. Minimum distance between the resection border and the illustrated PT was measured on postoperative tractography.</p>
<p style="text-align: justify;">RESULTS: In all subjects, DT imaging-based tractography of the PT was successfully performed, preoperatively demonstrating the relationship between tumors and the PT. With the use of the tractography-integrated navigation system and intraoperative MEPs, motor function was preserved postoperatively in all patients. A significant correlation was seen between threshold intensity for subcortical MEPs and the distance between the resection border and PT on postoperative DT imaging.</p>
<p style="text-align: justify;">CONCLUSION: DT imaging-based fiber tracking is a reliable and accurate method for mapping the course of subcortical PTs. Fiber tracking and intraoperative MEPs were useful for preserving motor function in patients with gliomas near the PT.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3776/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Prospective, Randomized Trial Comparing Expansile Cervical Laminoplasty and Cervical Laminectomy and Fusion for Multilevel Cervical Myelopathy</title>
		<link>http://www.neurosurgery-blog.com/archives/3765</link>
		<comments>http://www.neurosurgery-blog.com/archives/3765#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:00:16 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Spine]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Cervical]]></category>
		<category><![CDATA[fusion]]></category>
		<category><![CDATA[laminoplasty]]></category>
		<category><![CDATA[myelopathy]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3765</guid>
		<description><![CDATA[Neurosurgery 70:264–277, 2012 DOI: 10.1227/NEU.0b013e3182305669
Controversy exists as to the best posterior operative procedure to treat multilevel compressive cervical spondylotic myelopathy.
OBJECTIVE: To determine clinical, radiological, and patient satisfaction outcomes between expansile cervical laminoplasty (ECL) and cervical laminectomy and fusion (CLF).
METHODS: We performed a prospective, randomized study of ECL vs CLF in patients suffering from cervical spondylotic [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/A_Prospective_Randomized_Trial_Comparing.jpg"><img class="alignleft size-thumbnail wp-image-3768" title="A_Prospective,_Randomized_Trial_Comparing" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/02/A_Prospective_Randomized_Trial_Comparing-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 70:264–277, 2012 DOI: 10.1227/NEU.0b013e3182305669</strong></p>
<p style="text-align: justify;">Controversy exists as to the best posterior operative procedure to treat multilevel compressive cervical spondylotic myelopathy.</p>
<p style="text-align: justify;">OBJECTIVE: To determine clinical, radiological, and patient satisfaction outcomes between expansile cervical laminoplasty (ECL) and cervical laminectomy and fusion (CLF).</p>
<p style="text-align: justify;">METHODS: We performed a prospective, randomized study of ECL vs CLF in patients suffering from cervical spondylotic myelopathy. End points included the Short Form-36, Neck Disability Index, Visual Analog Scale, modified Japanese Orthopedic Association score, Nurick score, and radiographic measures.</p>
<p style="text-align: justify;">RESULTS: A survey of academic North American spine surgeons (n = 30) demonstrated that CLF is the most commonly used (70%) posterior procedure to treat multilevel spondylotic cervical myelopathy. A total of 16 patients were randomized: 7 to CLF and 9 to ECL. Both groups showed improvements in their Nurick grade and Japanese Orthopedic Association score postoperatively, but only the improvement in the Nurick grade for the ECL group was statistically significant (P &lt; .05). The cervical range of motion between C2 and C7 was reduced by 75% in the CLF group and by only 20% in the ECL group in a comparison of preoperative and postoperative range of motion. The overall increase in canal area was significantly (P &lt; .001) greater in the CLF group, but there was a suggestion that the adjacent level was more narrowed in the CLF group in as little as 1 year postoperatively.</p>
<p style="text-align: justify;">CONCLUSION: In many respects, ECL compares favorably to CLF. Although the patient numbers were small, there were significant improvements in pain measures in the ECL group while still maintaining range of motion. Restoration of spinal canal area was superior in the CLF group.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3765/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Midterm outcome after a microsurgical unilateral approach for bilateral decompression of lumbar degenerative spondylolisthesis</title>
		<link>http://www.neurosurgery-blog.com/archives/3750</link>
		<comments>http://www.neurosurgery-blog.com/archives/3750#comments</comments>
		<pubDate>Sun, 29 Jan 2012 23:00:15 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Spine]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Clinical outcome]]></category>
		<category><![CDATA[degenerative spondylolisthesis]]></category>
		<category><![CDATA[unilateral approach]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3750</guid>
		<description><![CDATA[J Neurosurg Spine 16:68–76, 2012. DOI: 10.3171/2011.7.SPINE11222
The aim of this study was to evaluate the results and effectiveness of bilateral decompression via a unilateral approach in the treatment of lumbar degenerative spondylolisthesis (DS).
Methods. Operations were performed in 84 selected patients (mean age 62.1 ± 10 years) with lumbar DS between the years 2001 and 2008. [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/New-approach-for-degenerative-spondylolisthesis.jpg"><img class="alignleft size-thumbnail wp-image-3755" title="New approach for degenerative spondylolisthesis" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/New-approach-for-degenerative-spondylolisthesis-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg Spine 16:68–76, 2012. DOI: 10.3171/2011.7.SPINE11222</strong></p>
<p style="text-align: justify;">The aim of this study was to evaluate the results and effectiveness of bilateral decompression via a unilateral approach in the treatment of lumbar degenerative spondylolisthesis (DS).</p>
<p style="text-align: justify;">Methods. Operations were performed in 84 selected patients (mean age 62.1 ± 10 years) with lumbar DS between the years 2001 and 2008. The selection criteria included lower back pain with or without sciatica, neurogenic claudication that had not improved after at least 6 months of conservative treatment, and a radiological diagnosis of Grade I DS and lumbar stenosis. Decompression was performed at 3 levels in 15.5%, 2 levels in 54.8%, and 1 level in 29.7% of the patients with 1 level of spondylolisthesis. All patients were followed up for at least 24 months. For clinical evaluations, a visual analog scale, Oswestry Disability Index (ODI), and Neurogenic Claudication Outcome Score (NCOS) were used. Spinal canal size and (neutral and dynamic) slip percentages were measured both pre- and postoperatively.</p>
<p style="text-align: justify;">Results. Neutral and dynamic slip percentages did not significantly change after surgery (p = 0.67 and p = 0.63, respectively). Spinal canal size increased from 50.6 ± 5.9 to 102.8 ± 9.5 mm2 (p &lt; 0.001). The ODI decreased significantly in both the early and late follow-up evaluations, and good or excellent results were obtained in 64 cases (80%). The NCOS demonstrated significant improvement in the late follow-up results (p &lt; 0.001). One patient (1.2%) required secondary fusion during the follow-up period.</p>
<p style="text-align: justify;">Conclusions. Postoperative clinical improvement and radiological findings clearly demonstrated that the unilateral approach for treating 1-level and multilevel lumbar spinal stenosis with DS is a safe, effective, and minimally invasive method in terms of reducing the need for stabilization.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3750/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Localization of Primary Language Areas by Arcuate Fascicle Fiber Tracking</title>
		<link>http://www.neurosurgery-blog.com/archives/3721</link>
		<comments>http://www.neurosurgery-blog.com/archives/3721#comments</comments>
		<pubDate>Mon, 23 Jan 2012 23:00:07 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Functional]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Arcuate fascicle]]></category>
		<category><![CDATA[Broca]]></category>
		<category><![CDATA[Fiber tracking]]></category>
		<category><![CDATA[Neuronavigation]]></category>
		<category><![CDATA[Wernicke]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3721</guid>
		<description><![CDATA[Neurosurgery 70:56–65, 2012 DOI: 10.1227/NEU.0b013e31822cb882
To reduce the risk of disabling postoperative functional deficit in patients with lesions in the dominant hemisphere, information about the localization of eloquent language areas is mandatory.
OBJECTIVE: To demonstrate the feasibility of arcuate fascicle (AF) tractography for proper localization of eloquent language areas in the superior temporal (STG) and inferior frontal [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Localization_of_Primary_Language_Areas_by_Arcuate-1.jpg"><img class="alignleft size-thumbnail wp-image-3725" title="Localization_of_Primary_Language_Areas_by_Arcuate-1" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Localization_of_Primary_Language_Areas_by_Arcuate-1-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 70:56–65, 2012 DOI: 10.1227/NEU.0b013e31822cb882</strong></p>
<p style="text-align: justify;">To reduce the risk of disabling postoperative functional deficit in patients with lesions in the dominant hemisphere, information about the localization of eloquent language areas is mandatory.</p>
<p style="text-align: justify;">OBJECTIVE: To demonstrate the feasibility of arcuate fascicle (AF) tractography for proper localization of eloquent language areas in the superior temporal (STG) and inferior frontal gyrus (IFG).</p>
<p style="text-align: justify;">METHODS: Between January and June 2010, we performed surgery in 13 patients with highly eloquent lesions with close spatial relationship to the primary language areas. All of them received preoperative diffusion tensor imaging for AF tractography. The STG and IFG were delineated at the ends of the AF. Five patients underwent functional magnetic resonance imaging of the primary language areas. The results were compared with tractography.</p>
<p style="text-align: justify;">RESULTS: Tractography of the AF without prior knowledge of the localization of the STG and IFG was feasible in all cases. In the cases with functional magnetic resonance imaging, the activation maps matched the tractography results. In all but 1 patient, preservation of the primary language areas was possible, proven by the good neurological outcome. One patient suffered from a language dysfunction caused by a lesion in the medial and inferior temporal gyrus along the surgical pathway.</p>
<p style="text-align: justify;">CONCLUSION: Tractography of the AF is a useful tool for identification of parts of the main primary language areas. Using tractography as a localization procedure to determine the primary language areas aids in the delineation of the STG and IFG and thus may help reduce the risk of postoperative permanent neurological deficit.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3721/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Experience in Using the Excimer Laser–Assisted Nonocclusive Anastomosis Nonocclusive Bypass Technique for High-Flow Revascularization: Mannheim-Helsinki Series of 64 Patients</title>
		<link>http://www.neurosurgery-blog.com/archives/3681</link>
		<comments>http://www.neurosurgery-blog.com/archives/3681#comments</comments>
		<pubDate>Sun, 15 Jan 2012 23:00:11 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[Aneurysm]]></category>
		<category><![CDATA[ELANA]]></category>
		<category><![CDATA[Excimer laser]]></category>
		<category><![CDATA[Nonocclusive bypass]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3681</guid>
		<description><![CDATA[Neurosurgery 70:49–55, 2012 DOI: 10.1227/NEU.0b013e31822cb979
The excimer laser–assisted nonocclusive anastomosis (ELANA) technique enables large-caliber bypass revascularization without temporary occlusion of the parent artery.
OBJECTIVE: To present the surgical experience of 2 bypass centers using ELANA in the treatment of complex intracranial lesions.
METHODS: Between July 2002 and December 2007, 64 consecutive patients (37 in Germany and 27 in [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Experience_in_Using_the_Excimer_Laser_Assisted.jpg"><img class="alignleft size-thumbnail wp-image-3684" title="Experience_in_Using_the_Excimer_Laser_Assisted" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Experience_in_Using_the_Excimer_Laser_Assisted-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 70:49–55, 2012 DOI: 10.1227/NEU.0b013e31822cb979</strong></p>
<p style="text-align: justify;">The excimer laser–assisted nonocclusive anastomosis (ELANA) technique enables large-caliber bypass revascularization without temporary occlusion of the parent artery.</p>
<p style="text-align: justify;">OBJECTIVE: To present the surgical experience of 2 bypass centers using ELANA in the treatment of complex intracranial lesions.</p>
<p style="text-align: justify;">METHODS: Between July 2002 and December 2007, 64 consecutive patients (37 in Germany and 27 in Finland) were selected for high-flow bypass surgery with ELANA. Modified Rankin Scale, a bypass success rate, and the success rate of the laser arteriotomy were assessed.</p>
<p style="text-align: justify;">RESULTS: In 66 surgeries for 64 intent-to-treat patients, 58 ELANA procedures were completed successfully. A favorable outcome (postoperative modified Rankin Scale score less than or equal to preoperative modified Rankin Scale) at 3 months was achieved in 43 of 56 patients (77%) with anterior circulation lesions (37 of the 43 patients had aneurysms, 4 had ischemia, and 2 received a bypass before tumor removal) and only in 2 of 8 patients (25%) with posterior circulation aneurysms. Perioperative (, 7 days) mortality for anterior and posterior circulation aneurysms was 6% and 50%, respectively. At the 3-month follow-up, 12% and 63% of patients with anterior and posterior circulation aneurysms, respectively, were dead. The success rate of the laser arteriotomy was 70%. Another 14% were retrieved manually after a nearly complete laser arteriotomy.</p>
<p style="text-align: justify;">CONCLUSION: The ELANA procedure requires a meticulous and careful operative technique. Morbidity and especially mortality rates, usually unrelated to ELANA, are comparable to those of contemporary series of conventional high-flow revascularization operations. This underscores the overall complexity of treating neurovascular pathologies by high-flow bypasses.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3681/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Barrow Ruptured Aneurysm Trial</title>
		<link>http://www.neurosurgery-blog.com/archives/3623</link>
		<comments>http://www.neurosurgery-blog.com/archives/3623#comments</comments>
		<pubDate>Tue, 03 Jan 2012 23:00:19 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Clinical Trial]]></category>
		<category><![CDATA[Endovascular]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Vascular]]></category>
		<category><![CDATA[clip occlusion]]></category>
		<category><![CDATA[Coil embolization]]></category>
		<category><![CDATA[Intracranial aneurysm]]></category>
		<category><![CDATA[randomized trial]]></category>
		<category><![CDATA[Subarachnoid hemorrhage]]></category>
		<category><![CDATA[vascular disorders]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3623</guid>
		<description><![CDATA[J Neurosurg 116:135–144, 2012.DOI: 10.3171/2011.8.JNS101767
The purpose of this ongoing study is to compare the safety and efficacy of microsurgical clipping and endovascular coil embolization for the treatment of acutely ruptured cerebral aneurysms and to determine if one treatment is superior to the other by examining clinical and angiographic outcomes. The authors examined the null hypothesis [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/aneurysms-of-the-middle-cerebral-artery.jpg"><img class="alignleft size-thumbnail wp-image-3624" title="aneurysms of the middle cerebral artery" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/aneurysms-of-the-middle-cerebral-artery-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg 116:135–144, 2012.DOI: 10.3171/2011.8.JNS101767</strong></p>
<p style="text-align: justify;">The purpose of this ongoing study is to compare the safety and efficacy of microsurgical clipping and endovascular coil embolization for the treatment of acutely ruptured cerebral aneurysms and to determine if one treatment is superior to the other by examining clinical and angiographic outcomes. The authors examined the null hypothesis that no difference exists between the 2 treatment modalities in the setting of subarachnoid hemorrhage (SAH). The current report is limited to the clinical results at 1 year after treatment.</p>
<p style="text-align: justify;">Methods. The authors screened 725 patients with SAH, resulting in 500 eligible patients who were enrolled prospectively in the study after giving their informed consent. Patients were assigned in an alternating fashion to surgical aneurysm clipping or endovascular coil therapy. Intake evaluations and outcome measurements were collected by nurse practitioners independent of the treating surgeons. Ultimately, 238 patients were assigned to aneurysm clipping and 233 to coil embolization. The 2 treatment groups were well matched. There were no anatomical exclusions. Crossing over was allowed, but primary outcome analysis was based on the initial treatment modality assignment. Posttreatment care was standardized for both groups. Patient outcomes at 1 year were independently assessed using the modified Rankin Scale (mRS). A poor outcome was defined as an mRS score &gt; 2 at 1 year. The primary outcome was based on the assigned group; that is, by intent to treat.</p>
<p style="text-align: justify;">Results. One year after treatment, 403 patients were available for evaluation. Of these, 358 patients had actually undergone treatment. The remainder either died before treatment or had no identifiable source of SAH. A poor outcome (mRS score &gt; 2) was observed in 33.7% of the patients assigned to aneurysm clipping and in 23.2% of the patients assigned to coil embolization (OR 1.68, 95% CI 1.08–2.61; p = 0.02). Of treated patients assigned to the coil group, 124 (62.3%) of the 199 who were eligible for any treatment actually received endovascular coil embolization. Patients who crossed over from coil to clip treatment fared worse than patients assigned to coil embolization, but no worse than patients assigned to clip occlusion. No patient treated by coil embolization suffered a recurrent hemorrhage.</p>
<p style="text-align: justify;">Conclusions. One year after treatment, a policy of intent to treat favoring coil embolization resulted in fewer poor outcomes than clip occlusion. Although most aneurysms assigned to the coil treatment group were treated by coil embolization, a substantial number crossed over to surgical clipping. Although a policy of intent to treat favoring coil embolization resulted in fewer poor outcomes at 1 year, it remains important that high-quality surgical clipping be available as an alternative treatment modality.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3623/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thoracoscopic Resection of Symptomatic Herniated Thoracic Discs</title>
		<link>http://www.neurosurgery-blog.com/archives/3607</link>
		<comments>http://www.neurosurgery-blog.com/archives/3607#comments</comments>
		<pubDate>Sun, 01 Jan 2012 10:13:44 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Spine]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[endoscopic spine surgery]]></category>
		<category><![CDATA[herniated thoracic disc]]></category>
		<category><![CDATA[thoracic discectomy]]></category>
		<category><![CDATA[Thoracoscopic discectomy]]></category>
		<category><![CDATA[Thoracoscopy]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3607</guid>
		<description><![CDATA[Spine 2012 ; 37 : 35 – 40
Study Design. Retrospective review of a prospectively maintained surgical database.
Objective. To report the indications, surgical procedures performed, and outcomes from the largest series of thoracoscopically treated herniated thoracic discs (HTDs). We also compared approach-related complications with an unmatched cohort undergoing thoracotomy for HTD.
Summary of Background Data. Symptomatic HTDs [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Th.Disc-herniation.jpg"><img class="alignleft size-thumbnail wp-image-3608" title="Th.Disc herniation" src="http://www.neurosurgery-blog.com/wp-content/uploads/2012/01/Th.Disc-herniation-150x150.jpg" alt="" width="150" height="150" /></a>Spine 2012 ; 37 : 35 – 40</strong></p>
<p style="text-align: justify;">Study Design. Retrospective review of a prospectively maintained surgical database.</p>
<p style="text-align: justify;">Objective. To report the indications, surgical procedures performed, and outcomes from the largest series of thoracoscopically treated herniated thoracic discs (HTDs). We also compared approach-related complications with an unmatched cohort undergoing thoracotomy for HTD.</p>
<p style="text-align: justify;">Summary of Background Data. Symptomatic HTDs are rare, and their surgical management is technically challenging.</p>
<p style="text-align: justify;">Methods. A prospectively maintained surgical database of all patients undergoing surgery for symptomatic HTDs by the senior author (blinded for review) was reviewed. As needed, the database was supplemented with hospital and clinic charts and telephone conversations with patients. A triportal method of thoracoscopic discectomy was performed in all cases.</p>
<p style="text-align: justify;">Results. Between 1994 and 2008, 121 patients underwent 125 thoracoscopic-assisted operations for 139 HTDs. Their mean age at surgery was 46.6 years. Indications for thoracoscopic resection currently include small symptomatic disc, anterior location, nonmorbidly obese patient, favorable chest anatomy, and T4–T11 location. Symptom duration averaged 32 months. Radiculopathy was the most common presentation, followed by myelopathy and pain (radiculopathic or back). The mean hospital stay was 4.8 days. Chest tubes remained in place for a mean of 3.2 days. At a mean follow-up of 2.4 years, myelopathy, radiculopathy, and back pain had resolved or improved at a rate of 91.1%, 97.6%, and 86.5%,of cases, respectively. Most patients (97.4%) would be willing to undergo the operation again. The complication rate was acceptable. Patients undergoing thoracoscopic excision had less approachrelated morbidity than an unmatched cohort undergoing excision using thoracotomy.</p>
<p style="text-align: justify;">Conclusion. Thoracoscopic-assisted microsurgical resection is a safe, effective, and minimally invasive method of treating symptomatic HTDs in appropriately selected patients. The symptoms of most patients improve or resolve with minimal morbidity.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3607/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Supraorbital Endoscopic Approach to Colloid Cysts</title>
		<link>http://www.neurosurgery-blog.com/archives/3552</link>
		<comments>http://www.neurosurgery-blog.com/archives/3552#comments</comments>
		<pubDate>Mon, 19 Dec 2011 23:00:52 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Developmental Malformations]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[Colloid cyst]]></category>
		<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[supraorbital approach]]></category>
		<category><![CDATA[Third ventricle]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3552</guid>
		<description><![CDATA[Neurosurgery 69[ONS Suppl 2]:ons176–ons183, 2011 DOI: 10.1227/NEU.0b013e318219563c
Surgical approaches to colloid cysts of the third ventricle have evolved over time. In recent years, endoscopy has been recognized as an effective alternative to open surgery. The disadvantage of endoscopic treatment is the difficulty in controlling the adhesion of the cyst to the roof of the third ventricle [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/12/Supraorbital_Endoscopic_Approach_to_Colloid_Cysts.jpg"><img class="alignleft size-thumbnail wp-image-3558" title="Supraorbital_Endoscopic_Approach_to_Colloid_Cysts" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/12/Supraorbital_Endoscopic_Approach_to_Colloid_Cysts-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 69[ONS Suppl 2]:ons176–ons183, 2011 DOI: 10.1227/NEU.0b013e318219563c</strong></p>
<p style="text-align: justify;">Surgical approaches to colloid cysts of the third ventricle have evolved over time. In recent years, endoscopy has been recognized as an effective alternative to open surgery. The disadvantage of endoscopic treatment is the difficulty in controlling the adhesion of the cyst to the roof of the third ventricle and in obtaining complete removal of the cyst.</p>
<p style="text-align: justify;">OBJECTIVE: To design and carry out a supraorbital approach to obtain a better viewing angle of the cyst and better control of the adhesion of the cyst to the roof of the third ventricle.</p>
<p style="text-align: justify;">METHODS: From September 2005 to February 2008, we operated on 7 consecutive patients with colloid cysts in the third ventricle. All procedures were performed with the endoscopic supraorbital approach. The endoscopic procedure was performed with a rigid STORZ endoscope with 3 working channels. In 4 patients, the surgical supraorbital trajectory was planned with the help of a navigator.</p>
<p style="text-align: justify;">RESULTS: The procedures lasted between 60 and 110 minutes, including the registration on the navigation system. Near-total removal of the cyst was achieved in 6 patients. All patients were discharged within 6 days.</p>
<p style="text-align: justify;">CONCLUSION: Endoscopic treatment may be an effective and safe alternative to open surgical craniotomy. Our series shows that the endoscopic supraorbital endoscopic resection is a valuable approach to colloid cysts of the third ventricle.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3552/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Microsurgical Management of Hypoglossal Schwannomas Over 3 Decades: A Modified Grading Scale to Guide Surgical Approach</title>
		<link>http://www.neurosurgery-blog.com/archives/3429</link>
		<comments>http://www.neurosurgery-blog.com/archives/3429#comments</comments>
		<pubDate>Wed, 30 Nov 2011 23:00:15 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Outcome]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[skull base surgery]]></category>
		<category><![CDATA[Hypoglossal canal]]></category>
		<category><![CDATA[Hypoglossal schwannoma]]></category>
		<category><![CDATA[Jugular tubercle]]></category>
		<category><![CDATA[Occipital condyle]]></category>
		<category><![CDATA[Sural nerve]]></category>
		<category><![CDATA[Transcondylar approach]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3429</guid>
		<description><![CDATA[Neurosurgery 69[ONS Suppl 2]:ons121–ons140, 2011. DOI: 10.1227/NEU.0b013e31822a547b
Schwannomas originating from the hypoglossal nerve are extremely rare. Microsurgical resection with the goal for cure has traditionally been associated with a high risk of postoperative deficits.
OBJECTIVE: To summarize our clinical experience using tailored cranial base approaches for these formidable lesions.
METHODS: The clinical records of 13 patients were retrospectively [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/11/Microsurgical-Management-of-Hypoglossal-Schwannomas-Over-3-Decades-A-Modified-Grading-Scale-to-Guide-Surgical-Approach.jpg"><img class="alignleft size-thumbnail wp-image-3433" title="Microsurgical Management of Hypoglossal Schwannomas Over 3 Decades- A Modified Grading Scale to Guide Surgical Approach" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/11/Microsurgical-Management-of-Hypoglossal-Schwannomas-Over-3-Decades-A-Modified-Grading-Scale-to-Guide-Surgical-Approach-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurgery 69[ONS Suppl 2]:ons121–ons140, 2011. DOI: 10.1227/NEU.0b013e31822a547b</strong></p>
<p style="text-align: justify;">Schwannomas originating from the hypoglossal nerve are extremely rare. Microsurgical resection with the goal for cure has traditionally been associated with a high risk of postoperative deficits.</p>
<p style="text-align: justify;">OBJECTIVE: To summarize our clinical experience using tailored cranial base approaches for these formidable lesions.</p>
<p style="text-align: justify;">METHODS: The clinical records of 13 patients were retrospectively reviewed. In addition, all reported patients in the literature were reviewed. The extreme lateral infrajugular transcondylar-transtubercular exposure approach was used in all of our patients. Based on our experience and literature analysis, we propose the following modified grading scale to facilitate surgical planning: type A, intradural tumors; type B, dumbbell-shaped tumors; type C, extracranial tumors; and type D, peripheral tumors.</p>
<p style="text-align: justify;">RESULTS: All 13 patients underwent total, near-total, or subtotal tumor resection. Eight patients were men, 5 were women (mean age, 41.7 years). Sural nerve graft reconstruction for the hypoglossal nerve was performed in 4 patients. Three of the 4 patients in whom nerve reconstruction was performed regained satisfactory movement of their tongue. In the review of the literature, the mean patient age was 45.8 years. Patients presented with tongue atrophy (91.6%), headache (60.9%), and dysphagia (31.8%). The tumors were categorized as type A in 31.7% of these patients, type B in 38.6%, type C in 6.2%, and type D in 23.4%.</p>
<p style="text-align: justify;">CONCLUSION: The extreme lateral infrajugular transcondylar-transtubercular exposure approach, which is a modification of the extreme lateral suboccipital approach, provides sufficient exposure for most intracranial dumbbell-shaped hypoglossal schwannomas. Hypoglossal nerve reconstruction using a sural nerve graft improves tongue atrophy and movement for patients with resected nerves.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3429/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

